Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer

Table 2

Univariate and multivariate analyses of OS in the 143 stage III NSCLC patients.

Characteristics	Univariate analysis			Multivariate analysis
	HR	95% CI		HR	95% CI
RT modality
Hypo-RT	1			1
Con-RT	1.89	1.15–3.57	0.040	1.87	1.20–3.56	0.046
Age
<65	1
≥65	1.49	0.76–2.94	0.249	NA
Gender
Male	1
Female	0.51	0.12–2.11	0.351	NA
Tumor stage
IIIB	1			1
IIIA	0.50	0.26–0.97	0.041	0.57	0.29–1.12	0.103
PS
0	1
1	0.86	0.46–1.58	0.618	NA
Pathology
Adenocarcinoma	1			1
Nonadenocarcinoma	2.75	1.27–5.95	0.010	2.7	1.24–5.87	0.012
Chemotherapy type
Concurrent	1
Sequential	1.11	0.60–2.05	0.743	NA

OS: overall survival; NSCLC: non-small-cell lung cancer; RT: radiation therapy; Hypo-RT: hypofractionated RT; Con-RT: conventional RT; PS: performance status.